Quantcast

Latest Idenix Pharmaceuticals Inc. Stories

2010-04-15 03:23:00

CAMBRIDGE, Mass., April 15 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients. Data are being presented at the 45th annual meeting of the European Association...

2010-03-30 15:05:00

CAMBRIDGE, Mass., March 30 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has appointed Tamar D. Howson to its Board of Directors. Ms. Howson is currently a Partner at JSB-Partners, a transaction advisory firm serving the life sciences industry. Ms. Howson has extensive experience in licensing, collaborations and M&A...

2010-03-26 07:05:00

CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present a corporate overview at the upcoming Canaccord Adams' Hepatitis C Conference on Thursday, April 1, 2010 at 10:45 a.m. ET at The Peninsula Hotel, New York. The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes...

2010-03-17 15:05:00

CAMBRIDGE, Mass., March 17 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present a corporate overview at the upcoming Barclays Capital 2010 Global Healthcare Conference, March 24, 2010 at 8:30 a.m. ET at the Loews Miami Hotel, Florida. The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes...

2010-03-16 08:44:00

CAMBRIDGE, Mass., March 16 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that four abstracts have been accepted for presentation at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL, April 14-18, 2010 in Vienna, Austria). Full abstracts can now be viewed at the EASL website at www.easl.eu. The...

2010-03-02 15:05:00

CAMBRIDGE, Mass., March 2 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present a corporate overview at the upcoming Cowen and Company 30(th) Annual Health Care Conference on Monday, March 8, 2010 at 1:00 p.m. ET at The Boston Marriott Copley Place, Boston, MA. The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in...

2010-02-25 15:05:00

CAMBRIDGE, Mass., Feb. 25 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the fourth quarter and year ended December 31, 2009. At December 31, 2009, Idenix's cash, cash equivalents and marketable securities totaled $48.1 million. Business Highlights In the fourth quarter of 2009, Idenix initiated a...

2010-02-11 15:05:00

CAMBRIDGE, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX) announced today that it will report its financial results for the fourth quarter and year end 2009 on Thursday, February 25, 2010 after U.S. financial markets close. In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Thursday, February 25, 2010 to discuss the company's financial results for the fourth quarter of 2009 and...

2010-02-01 15:05:00

CAMBRIDGE, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the upcoming 12th Annual BIO CEO & Investor Conference on Monday, February 8, 2010 at 9:30 a.m. ET at the Waldorf-Astoria Hotel in New York, NY. The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in...

2010-01-11 05:45:00

CAMBRIDGE, Mass., Jan. 11 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced significant progress in three HCV programs. Idenix will provide a business update on these three HCV development programs and on its partnered programs during a presentation by Jean-Pierre Sommadossi, Ph.D., chairman and chief executive officer, to...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related